The Silent Epidemic: Quest For A Cure (Paperback or Softback)

"The concussion crisis has changed the face of sports as we know it and it has brought to surface the incredible importance of our brain health. The time is now for us to make our brain the number one priority so that education and awareness can take effect and begin to change the way we approach the health of our athletes from youth to professionals." -Ben Utech, Ambassador, The American Academy of Neurology.

"The Silent Epidemic: Quest For A Cure chronicles the distinguished academic career of neuroscientist Michel Baudry, a story of the ecstatic ups and awful downs of a life wading through the research trenches. Baudry's particular trenches led, dimly at times, to an explanation of a group of enzymes called calpains. That said, the book is not about enzymes; it's about the eternal struggle of science and the astonishing commitment of scientists like Baudry. Especially in our current moment, the broader public would benefit from understanding the nobility of that struggle."

-Terry McDermont, author of 101 Theory Drive: A Neuroscientist's Quest for Memory

The Silent Epidemic: Quest For A Cure, chronicles the distinguished academic career of neuroscientist Michel Baudry, a story of the ecstatic ups and awful downs of a life wading through the research trenches. Baudry's particular trenches led, dimly at times, to an explanation of a group of enzymes called calpains. That said, the book is not about enzymes; it's about the eternal struggle of science and the astonishing commitment of scientists like Baudry. Especially in our current moment, the broader public would benefit from understanding the nobility of that struggle.

Dr. Michel Baudry is currently Professor of Biomedical Sciences in the Graduate College of Biomedical Sciences at Western University of Health Sciences in Pomona, CA. His previous position was Professor of Biological Sciences, Neurology and Biomedical Engineering at USC, Los Angeles, CA.Dr. Baudry is a world-known neuroscientist and has published over400 manuscripts in peer-reviewed journals. He is one of the 100 most cited neuroscientists, according to the ISI database.

Dr. Stella Sung is a life science/biotech executive with 25 years of experience in both operating and venture capital roles. She is the CEO of NeurAegis, Inc. as well as a member of its Board of Directors. Dr. Sung has been a "C-level" executive (CEO/ CBO) at multiple life science companies, including AEGEA Biotechnologies, Decoy Biosystems, ImmunoActiva, Tauriga Sciences, Avita Medical, PliCare Therapeutics and Cylene Pharmaceuticals. Dr. Sung received her Ph.D. in chemistry from Harvard University, where she was a National Science Foundation Predoctoral Fellow, and her B.S. in chemistry with a minor in English from Ohio State University, Phi Beta Kappa.